Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review.

Mann BS, Barnieh L, Tang K, Campbell DJ, Clement F, Hemmelgarn B, Tonelli M, Lorenzetti D, Manns BJ.

PLoS One. 2014 Mar 25;9(3):e89168. doi: 10.1371/journal.pone.0089168. eCollection 2014. Review.

2.

A systematic review of value-based insurance design in chronic diseases.

Tang KL, Barnieh L, Mann B, Clement F, Campbell DJ, Hemmelgarn BR, Tonelli M, Lorenzetti D, Manns BJ.

Am J Manag Care. 2014 Jun;20(6):e229-41. Review.

PMID:
25326932
3.

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Acosta A, Ciapponi A, Aaserud M, Vietto V, Austvoll-Dahlgren A, Kösters JP, Vacca C, Machado M, Diaz Ayala DH, Oxman AD.

Cochrane Database Syst Rev. 2014 Oct 16;(10):CD005979. doi: 10.1002/14651858.CD005979.pub2. Review.

PMID:
25318966
4.

Pharmaceutical policies: effects of cap and co-payment on rational drug use.

Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017. doi: 10.1002/14651858.CD007017. Review. Update in: Cochrane Database Syst Rev. 2015;5:CD007017.

PMID:
18254125
5.

Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.

Aaserud M, Dahlgren AT, Kösters JP, Oxman AD, Ramsay C, Sturm H.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD005979. Review. Update in: Cochrane Database Syst Rev. 2014;10:CD005979.

PMID:
16625648
6.

Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review.

Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN.

Ann Intern Med. 2012 Dec 4;157(11):785-95. Review.

PMID:
22964778
7.
8.

Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies.

Choudhry NK, Brennan T, Toscano M, Spettell C, Glynn RJ, Rubino M, Schneeweiss S, Brookhart AM, Fernandes J, Mathew S, Christiansen B, Antman EM, Avorn J, Shrank WH.

Am Heart J. 2008 Jul;156(1):31-6. doi: 10.1016/j.ahj.2008.03.021. Epub 2008 Jun 6.

9.

Increasing time costs and copayments for prescription drugs: an analysis of policy changes in a complex environment.

Domino ME, Martin BC, Wiley-Exley E, Richards S, Henson A, Carey TS, Sleath B.

Health Serv Res. 2011 Jun;46(3):900-19. doi: 10.1111/j.1475-6773.2010.01237.x. Epub 2011 Feb 9.

10.

Managing patients with multimorbidity: systematic review of interventions in primary care and community settings.

Smith SM, Soubhi H, Fortin M, Hudon C, O'Dowd T.

BMJ. 2012 Sep 3;345:e5205. doi: 10.1136/bmj.e5205. Review.

11.

Prescription drugs: issues of cost, coverage, and quality.

Copeland C.

EBRI Issue Brief. 1999 Apr;(208):1-21.

PMID:
10539445
12.

A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development.

Barnieh L, Clement F, Harris A, Blom M, Donaldson C, Klarenbach S, Husereau D, Lorenzetti D, Manns B.

PLoS One. 2014 Mar 11;9(3):e90434. doi: 10.1371/journal.pone.0090434. eCollection 2014. Review.

13.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
14.

The global impact of non-communicable diseases on households and impoverishment: a systematic review.

Jaspers L, Colpani V, Chaker L, van der Lee SJ, Muka T, Imo D, Mendis S, Chowdhury R, Bramer WM, Falla A, Pazoki R, Franco OH.

Eur J Epidemiol. 2015 Mar;30(3):163-88. doi: 10.1007/s10654-014-9983-3. Epub 2014 Dec 21. Review.

PMID:
25527371
15.

A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.

Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G.

Health Technol Assess. 2001;5(28):1-110. Review.

16.

Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.

Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart J, Vrijens B; ABC project team.

Drugs. 2013 May;73(6):545-62. doi: 10.1007/s40265-013-0041-3. Review.

17.

Cost-sharing and adherence to antihypertensives for low and high adherers.

Yoon J, Ettner SL.

Am J Manag Care. 2009 Nov;15(11):833-40.

18.

Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.

Schneeweiss S, Patrick AR, Maclure M, Dormuth CR, Glynn RJ.

Circulation. 2007 Apr 24;115(16):2128-35. Epub 2007 Apr 9.

19.

The effect of financial incentives on the quality of health care provided by primary care physicians.

Scott A, Sivey P, Ait Ouakrim D, Willenberg L, Naccarella L, Furler J, Young D.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008451. doi: 10.1002/14651858.CD008451.pub2. Review.

PMID:
21901722
20.

The effect of copayments for prescriptions on adherence to prescription medicines in publicly insured populations; a systematic review and meta-analysis.

Sinnott SJ, Buckley C, O'Riordan D, Bradley C, Whelton H.

PLoS One. 2013 May 28;8(5):e64914. doi: 10.1371/journal.pone.0064914. Print 2013. Review.

Items per page

Supplemental Content

Write to the Help Desk